HomePL3 • FRA
add
TuHURA Biosciences Inc
Previous close
€2.04
Year range
€1.79 - €3.62
Market cap
118.05M USD
Avg Volume
63.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
The Globe and Mail
21 hours ago
TSX falls the most in six months as gold slides and inflation heats up
1.73%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.98M | 65.14% |
Net income | -9.52M | -80.88% |
Net profit margin | — | — |
Earnings per share | -0.21 | — |
EBITDA | -5.96M | -66.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.51M | — |
Total assets | 34.62M | — |
Total liabilities | 15.17M | — |
Total equity | 19.45M | — |
Shares outstanding | 50.05M | — |
Price to book | 5.37 | — |
Return on assets | -60.66% | — |
Return on capital | -99.50% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.52M | -80.88% |
Cash from operations | -6.25M | -23.34% |
Cash from investing | -156.46K | -328.69% |
Cash from financing | 8.70M | -32.85% |
Net change in cash | 2.29M | -70.79% |
Free cash flow | 10.35M | — |
About
Founded
1995
Headquarters
Website
Employees
19
